Peritoneal ultrafiltration for refractory heart failure: single-center experience
█ Original article
P. Szabó Réka1, Pethő Ákos2, Fedor Roland3, Kertész Attila4, Bódi Annamária4, Szegedi Andrea4, Balla József5
1DE ÁOK, Sebészeti Intézet, Debrecen
2Semmelweis Egyetem I. sz. Belgyógyászati Klinika, Budapest
3DE ÁOK, Sebészeti Intézet, Debrecen
4DE ÁOK, Kardiológiai Intézet, Debrecen
5DE ÁOK, Belgyógyászati Intézet, FMC-Debrecen, Extrakorporális Szervpótló Centrum, Debrecen
Introduction: In our centre we have been treated patients with therapy refracter congestive heart failure. The aim of this study was to describe a single-center experience in the treatment of refractory HF patients with peritoneal dialysis (PD).
Methods: Our study included in a single PD Unit, showing symptoms and signs of severe refractory congestive HF to optimal pharmacological therapy (NYHA class IV). We followed them till January 2018.
Results: Patients were followed for 10 months; population mean age was 58 years and Charlson’s comorbidity index was 6–10. We could start peritoneal dialysis immediately after catheter implantation. Three patients died but not according to PD associated infection: 1 traumatic, 1 due to HF, another patient due to infection.
Conclusion: PD, applied to refractory HF can improve functional class. In Hungary we used peritoneal dialysis first time as a bridge therapy to heart transplantation in diuretic refracter heart failure.